Conference Coverage

Metabolic syndrome scoring system predicts CVD in type 2 diabetes


 

REPORTING FROM ENDO 2018

A scoring system that addresses severity of metabolic syndrome successfully predicted risk for future coronary heart disease in individuals with type 2 diabetes; the system identified the association independent of hemoglobin A1c levels, according to work presented at the annual meeting of the Endocrine Society.

The findings may point toward an additional surveillance tool for coronary heart disease (CHD) in patients who have type 2 diabetes, according to Mark D. DeBoer, MD, and his coauthors, who had not previously applied the metabolic syndrome severity scoring system to individuals with diabetes.

Dr. Mark D. DeBoer of the department of pediatrics and the Child Health Research Center at the University of Virginia, Charlottesville Bruce Jancin/MDedge News

Dr. Mark D. DeBoer

When broken down by quartile, increasing severity of metabolic syndrome for individuals with type 2 diabetes was associated with an increased risk of future cardiovascular disease, even when blood glucose levels were not included in calculation of metabolic syndrome (P less than .001 with glucose levels and P = .001 without glucose levels).

Dr. DeBoer, of the department of pediatrics and the Child Health Research Center at the University of Virginia, Charlottesville, and his coinvestigators, had previously developed the continuous scoring system for metabolic syndrome. The system incorporates the components that form the diagnostic criteria for metabolic syndrome – waist circumference, systolic blood pressure, and levels of HDL cholesterol, triglycerides, and blood glucose.

However, rather than using cutoffs for a dichotomous score of 0 or 1 for each criterion, the investigators developed sex- and race/ethnicity-specific scores of severity. This approach may identify metabolic dysregulation that would not be apparent if measures of several different criteria were just short of missing the cutoff, for example.

“These scores are standardized like z scores such that 2.0 is two standard deviations above the mean,” wrote Dr. DeBoer and his colleagues. Thus, the scores are dubbed “MetS z scores;” a free online calculator is available.

In developing the model, the investigators performed single-factor confirmatory factor analyses using data from 6,870 adults from the National Health and Nutrition Examination Survey cohort, developing scores specific for non-Hispanic whites, non-Hispanic blacks, and Hispanics.

Pages

Recommended Reading

MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Endocrinology
FDA approves marketing for retinal imaging device that uses artificial intelligence
MDedge Endocrinology
VIDEO: Meta-analysis: Mortality, safety data may favor SGLT2 inhibitors in T2DM
MDedge Endocrinology
‘Fast food swamps’ linked to type 1 diabetes
MDedge Endocrinology
MDedge Daily News: Which diabetes drug boosts survival best?
MDedge Endocrinology
Targeting obesity could slow brain aging in psychosis
MDedge Endocrinology
Nitric oxide–generating dressing holds promise for diabetic foot ulcers
MDedge Endocrinology
Artificial pancreas treatment improves glycemic control in T1DM: Meta-analysis
MDedge Endocrinology
MDedge Daily News: Physician burnout needs more than yoga
MDedge Endocrinology
Hormone therapy raises diabetes risk in breast cancer survivors
MDedge Endocrinology